CONTACT US
Preclinical Oncology Services

Advance Cancer Treatment Breakthroughs

Carcinotech enhances precision in drug development and cancer treatment with 3D-bioprinted, patient-derived tumors and holistic assay services.
Explore Our Technology
3D tumoroid model.

We’re Carcinotech

We strive to ensure that individuals facing cancer can benefit from the most effective treatment options, improving both survival and quality of life.

By providing more relevant cancer models for testing, we help accelerate drug development and enhance personalized treatment decisions.

Learn More About Us

100+

Diverse and characterized tumor biopsies in our repository

20+

Different cell types included within our printed tumor models

9+

Treatment modalities advanced through the use of our cancer models

6

Years supporting the cancer research community

Unlock Efficiencies with our End-to-end Preclinical Oncology Services

SOURCE
PRINT
ASSESS

Biopsy Sourcing

With our extensive repository of tumor biopsies and sourcing capabilities, we can provide the specific cancer indications required for your study.

These biopsies are then utilized to 3D-print tumors tailored to your research needs.

Discover More

3D Tumor Development

Harness the power of precision with our assay-ready, cancer models, part of our comprehensive preclinical oncology services.

We create patient-derived tumors that retain their native microenvironment, offering you highly relevant models for drug testing, optimization, and precision medicine.

Discover More

Oncology Assays

Bridge resource gaps and accelerate your research with our expert scientific team.

We design and execute assays on your behalf, delivering the critical insights you need, faster and with precision.

Discover More

Supporting Oncology Drug Discovery and Preclinical Testing

Preclinical Oncology Services for Multiple Modalities

Discover What Sets Us Apart
Immunotherapies
Monoclonal Antibodies
Hormone Therapies
Cancer Vaccines
Targeted Therapies
Oncolytic Virus Therapies
Radioimmunotherapies
Chemotherapies
Gene Therapies
Immunotherapies
Cancer Vaccines
Radioimmuno therapies
Monoclonal Antibodies
Targeted Therapies
Chemotherapies
Hormone Therapies
Oncolytic Virus Therapies
Gene Therapies

Hear from our Partners

We are honored to collaborate with leading organizations dedicated to improving outcomes for cancer patients worldwide.
  • “The Carcinotech team went above and beyond to source and 3D-print the rare cancer model essential for our preclinical study.”
    McRae
    VP of Research, Biotech Organization